Zoetis Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares rose 3.68% to $76.68 on Wednesday, marking its second consecutive day of gains. Despite the daily increase, Zoetis underperformed compared to competitors like Merck & Co., which surged 12.60%. Trading volume was below the 50-day average, and the stock remains significantly below its 52-week high.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) rose 3.68% to $76.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.
This was the stock's second consecutive day of gains.
Zoetis Inc. closed 52.22% short of its 52-week high of $160.48, which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Merck & Co. Inc. (MRK) rose 12.60% to $152.20 and IDEXX Laboratories Inc. (IDXX) rose 1.60% to $562.20.
Trading volume (5.2 M) remained 1.6 million below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-19-26 1657ET